122 related articles for article (PubMed ID: 4341810)
21. [Renin-angiotensin-aldosterone system: effect of the hypertensive agents on plasma renin activity and clinical application, especially in screening of primary aldosteronism and other simialr diseases].
Suzuki T
Jpn Circ J; 1970 Mar; 34(3):187-97. PubMed ID: 5468432
[No Abstract] [Full Text] [Related]
22. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
Davies DL; Beevers DG; Brown JJ; Cumming AM; Fraser R; Lever AF; Mason PA; Morton JJ; Robertson JI; Titterington M; Tree M
J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346
[No Abstract] [Full Text] [Related]
23. Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium-depleted man.
Kem DC; Gomez-Sanchez C; Kramer NJ; Holland OB; Higgins JR
J Clin Endocrinol Metab; 1975 Jan; 40(1):116-24. PubMed ID: 163263
[No Abstract] [Full Text] [Related]
24. Primary aldosteronism. Review of diagnostic tests and 15 cases.
Koppes G
J Kans Med Soc; 1972 May; 73(5):259-71 passim. PubMed ID: 5026873
[No Abstract] [Full Text] [Related]
25. [Renin and aldosterone].
Salvetti A; Acquaviva G; Sassano P; Arzilli F
Ann Ist Super Sanita; 1975; 11(1-2):72-97. PubMed ID: 1232875
[TBL] [Abstract][Full Text] [Related]
26. [Development and application of the radioimmunologic assay of plasma aldosterone and renin activity].
Corvol P; Ménard J; Auzan C; Gonzales MF
Ann Endocrinol (Paris); 1972; 33(3):285-6. PubMed ID: 4346621
[No Abstract] [Full Text] [Related]
27. Decrease in serum potassium levels post saline suppression test in primary aldosteronism: an under-recognised phenomenon?
Lee MH; Moxey JE; Derbyshire MM; Ward GM; MacIsaac RJ; Sachithanandan N
J Hum Hypertens; 2016 Nov; 30(11):664-665. PubMed ID: 26888603
[No Abstract] [Full Text] [Related]
28. Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.
Cornu E; Steichen O; Nogueira-Silva L; Küpers E; Pagny JY; Grataloup C; Baron S; Zinzindohoue F; Plouin PF; Amar L
Hypertension; 2016 Oct; 68(4):989-94. PubMed ID: 27600182
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
[TBL] [Abstract][Full Text] [Related]
30. Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism.
Fukuda N; Soma M; Kubo A; Kunimoto M; Watanabe Y; Izumi Y; Kanmatsuse K
J Endocrinol Invest; 1997 Jan; 20(1):13-7. PubMed ID: 9075066
[TBL] [Abstract][Full Text] [Related]
31. On the role of aldosterone to hypertension, especially an extent of its participation.
Oda T
Jpn Circ J; 1971 May; 35(5):513-8. PubMed ID: 4326119
[No Abstract] [Full Text] [Related]
32. Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man.
Katz FH; Romfh P; Smith JA
J Clin Endocrinol Metab; 1975 Jan; 40(1):125-34. PubMed ID: 1112870
[No Abstract] [Full Text] [Related]
33. Effect of aging on renin activity and aldosterone excretion.
Crane MG; Harris JJ
J Lab Clin Med; 1976 Jun; 87(6):947-59. PubMed ID: 932525
[TBL] [Abstract][Full Text] [Related]
34. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
35. Prolonged pseudoaldosteronism induced by glycyrrhizin.
Takeda R; Morimoto S; Uchida K; Nakai T; Miyamoto M; Hashiba T; Yoshimitsu K; Kim KS; Miwa U
Endocrinol Jpn; 1979 Oct; 26(5):541-7. PubMed ID: 393503
[TBL] [Abstract][Full Text] [Related]
36. [Excretion of aldosterone in the urine, renin activity in the plasma and some indices of the metabolism of potassium and sodium in patients with the iodiopathic edema syndrome].
Egart FM; Atamanova TM; Egorova IA; Korotkova VD; Golokhvostova IF
Probl Endokrinol (Mosk); 1975; 21(3):45-9. PubMed ID: 1144321
[TBL] [Abstract][Full Text] [Related]
37. Renin suppression by DOC and NaCl in the rat.
Pettinger WA; Marchelle M; Augusto L
Am J Physiol; 1971 Oct; 221(4):1071-4. PubMed ID: 4329425
[No Abstract] [Full Text] [Related]
38. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
[TBL] [Abstract][Full Text] [Related]
40. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Rössler R
Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
